Gadolinium Toxicity Lawsuit arrow

Ever Had An MRI With Contrast? If So, Do You Suffer From These Symptoms?

New Evidence Shows Contrast-Enhanced MRI’s May Lead to Toxic Levels of Gadolinium in the Body...

Known symptoms of gadolinium toxicity include...

  • Brain fog
  • Bone or joint pain
  • Memory loss
  • Sharp, cutting or burning pains in body
  • Muscle twitches or muscle weakness
  • Chronic headaches
  • Cognitive impairment
  • Nausea and/or vomiting
  • Intense burning sensation of skin
  • And many other symptoms...

AT A GLANCE: 1 out of 3 patients who undergo an MRI (or MRA) receive it “with contrast”, meaning the patient is injected with “Gadolinium”, a metal substance used to enhance the contrast of the images. However, recent evidence has shown many patients who receive contrast have toxic levels of gadolinium retained in their body, wreaking havoc on their health and causing a wide-range of symptoms and on-going health problems.


If you think you may have been affected by this, you may be eligible for financial compensation to cover your suffering and medical expenses.

Talk to one of our attorneys today. We are offering free legal consultations for a limited time. Click the button below to discover how you may benefit and what testing is available to find out if you are affected...

It's totally free and without obligation.

We are investigating cases across all 50 states.

Gadolinium Chuck Norris Wife Video

"We've been blessed enough to be able to afford the alternative or the integrative treatments, modalities and medicines that are out there [to treat gadolinium toxicity]. But there are millions of people that don't have that, because insurance doesn't pay. We've spent well over $1 million dollars, if not more, to save my life."

The Dangers of MRI's: Chuck Norris & His Wife Ring The Alarm

Please watch the remarkable video showing action star Chuck Norris and his wife Gena share the dramatic story of how Gena was unknowingly poisoned with toxic levels of gadolinium during three MRI’s where she was given contrast-enhancing dye. The video is a MUST watch.

MRI is a medical abbreviation for “magnetic resonance imaging”. MRI scans are used in radiology to take pictures showing the internals of the head or various sections of the body.

Approximately 1 out of 3 patients who undergo an MRI (or MRA) scan, are injected with a contrast-enhancing agent (sometimes called ‘dyes’, or ‘media’) to help improve the quality of the MRI images.

These contrast-enhancing agents are primarly made up of the metallic substance, gadolinium. A patient that undergoes an MRI with contrast is injected with Gadolinium BEFORE the MRI scan.

Did you receive a contrast-enhancing dye (gadolinium) with an MRI?

Continue reading...

Gadolinium Deposition Disease: The Toxic Retention of Gadolinium & The Associated Symptoms

Twenty-million patients each year undergo an MRI or MRA scan where they are injected with gadolinium-based contrast agents (”GBCA”).

In most of these patients, the injected GBCA (ie. gadolinium) is expelled by the body shortly after the scan. This is accomplished through normal urination.

However, recent studies have shown many patients are unable to expel the GBCA (gadolinium), and instead retain toxic levels of gadolinium in their brain, bones and organ tissue, causing a wide variety of on-going symptoms.

It was once believed by the medical community that only patients with impaired renal (kidney) function may have issues expelling the injected gadolinium from their systems.

But today's research clearly demonstrates that toxic gadolinium retention can occur in patients with healthy renal function. In other words, it can happen to anyone.

Patients with toxic gadolinium retention are said to have Gadolinium Deposition Disease -- the clinical name for this scary condition.

Continue reading...

Gadolinium Deposition Disease
Gadolinium toxicity symptoms

Symptoms Associated With Gadolinium Deposition Disease

The symptoms linked with toxic gadolinium retention are wide-ranging and many. Here are the most commonly reported symptoms...

  • Chronic headaches
  • Unexplained pains (ie. sharp, cutting or burning pains in the arms, legs or torso; tingling and/or prickling pains)
  • Deep bone and joint pains
  • Changes to skin (ie. tightness, thickening, lesions, changes in color, etc)
  • Cognitive impairment
  • Brain fog
  • Feelings of sharp pins and needles
  • Nausea and/or vomiting
  • Muscle twitches or severe weakness
  • Severe degredation of vision and dry eyes
  • Trouble with swallowing
  • Trouble speaking (weakening of voice)
  • Itching skin
  • Hair Loss

Did you develop any of the above symptoms linked to Gadolinium Deposition Disease (GDD)?

Continue reading...

FDA Issues “Black Box Warning” To Avoid Gadolinium-Based Contrast Agents (GBCAs) In Certain Patients...

The Food & Drug Administration (FDA) in 2007 issued its most severe warning concerning Gadolinium-based contrast agents, the “Black Box Warning”, urging the complete avoidance of gadolinium use in MRIs and MRAs -- but only for patients suspected or known to have impaired drug elimination.

At the time, the FDA did indeed acknowledge the serious issue of gadolinium retention in patients who underwent MRIs and MRAs, but basically only those with impaired renal (ie. kidney) function.

Now in 2018, there is a statistically sizeable amount of data and evidence that demonstrates the risk of toxic gadolinium retention in patients with perfectly normal and healthy renal function.

Scientists and the medical community are now urging the FDA to re-evaluate its warnings for Gadolinium use in MRI and MRA scans.

Continue reading...

Gadolinium Deposition Disease
Gadolinium FDA Warning

2017: FDA Votes 13-1, Recommending New Warnings Regarding Gandolinium Retention In Organs & Brain

In 2017, the FDA voted to issue new warnings and prescribing information for gandolinium-based contrast agents (GBCAs) in regards to toxic retention in patients’ organs and brain.

While much of the medical community felt this warning should have included stricter mandates, the FDA issued a statement stating adverse effects of gadolinium retention are “still under investigation”.

2017: Europe Recommends A Ban Suspending The Use of Gadolinium-Based Contrast Agents

The European Medicines Agency Committee, which is Europe’s version of our Food & Drug Administration, did move swiftly and aggressively after evaluating recent evidence -- recommending a ban suspending the use of gadolinium-based contrast agents (GBCAs) in patients undergoing MRIs.

Continue reading...

The Law Is Your Protection and Hope:

What To Do If You Think You May Be Affected By Gadolinium Toxicity

The law protects patients from dangerous drugs and chemicals that can cause serious health consequences.

If you (or a loved one) underwent an MRI (or MRA) with a contrast-enhancing injection, and feel you may be affected by gadolinium toxicity (medically referred to as 'Gadolinium Deposition Disease'), a conversation with a gadolinium toxicity attorney may be one of the most important things you can do.

As a result of the manufacturers of GBCAs failing to properly warn the public of these known risks, you or your loved one may have suffered significant health issues, emotional and physical stress, along with unintended financial burdens -- like doctor or hospital visits, time off work, necessary treatments and/or surgeries to treat your symptoms, and so on.

As such, you may be entitled to financial help in the form of legal compensation -- money awarded from individual lawsuits, settlements and/or class action lawsuits.

It’s Worth Speaking to An Attorney:

Get A Free Legal Consultation Today

Our legal team has reviewed the available evidence and our experience tells us that we are in prime position to represent victims who may be affected by toxic levels of gadolinium after undergoing an MRI or MRA scan.

We are currently accepting cases nationally from all 50 states.

For a limited time, our gadolinium toxicity lawyers are offering FREE legal consultations.

This is your opportunity to have a conversation with an experienced attorney who can answer all your questions and help you determine if you are eligible to pursue financial compensation.

Act Now Because There Is A Limited Window of Time To Pursue A Legal Case

There is a very small window of time for victims to seek financial compensation after an injury -- it is called the "statute of limitations" and the time window for pursuing a case is different in each state.

So please do not wait to speak to an attorney because you do not want to miss your opportunity to pursue a gadolinium deposition disease settlement or lawsuit.

Get Started By Taking Our 60-Second Risk Analysis

Click the button below to take our 60-second risk analysis and determine if you may be eligible to pursue financial compensation. We are offering free legal consultations to those who meet the criteria.

The legal consultations are with our well-informed gadolinium toxicity attorneys -- and there is no risk or obligation. It is simply your chance to learn about the latest developments, both medically and legally, and determine what your options are.

Our legal team is also offering free information about currently available 24-hr urine tests that may be available through your doctor, as we encourage everyone who feels they may be affected to seek this help and testing from their physician.

So please begin by clicking the button below...



You may also talk to our gadolinium attorneys for free.

No risk or obligation -- just valuable information to help.


Greenberg & Bederman, LLC
1111 Bonifant St
Silver Spring, MD 20910

Local: (No longer accepting) (24/7)
Toll-Free: (No longer accepting) (24/7)


The Law Office of Greenberg & Bederman has numerous attorneys that were awarded the prestigious Super Lawyers™ status. Super Lawyers™ is an independent, attorney ranking organization that awards attorneys each year based on many factors, including affinity with other lawyers.

Copyright © 2022 Greenberg & Bederman, LLC.
All Rights Reserved.

Greenberg & Bederman, LLC is associated with Bubalo Goode PLC

Click to Scroll to Top of Page